"Never doubt that a small group of thoughtful, committed citizens can change the world. Indeed, it is the only thing that ever has."

Margaret Mead
TO ARTICLE
METRICS

Case report
peer-reviewed

Neurological Complications of Coronavirus Disease (COVID-19): Encephalopathy


Total Article Reads

Article reads consist of online article views and PDF downloads. Cureus data is delayed by 24 hours and PMC data is delayed by approximately one month.

Total Article Reads Cureus PMC
91,410 Article Views 71,035 13,942
PDF Downloads 3,843 2,590
Total Article Reads Cureus PMC
91,410 Article Views 71,035 13,942
PDF Downloads 3,843 2,590
Total Article Reads
91,410
Cureus PMC
Article Views 71,035 13,942
PDF Downloads 3,843 2,590

Article Reads by Date

Hover your cursor over a specific day or month to see the corresponding online article views and PDF downloads. Cureus data is delayed by 24 hours and PMC data is delayed by approximately one month.

Cureus Article Reads

Loading...

Cumulative Cureus and PMC Article Reads

Loading...

Article Reads by Country

Hover your cursor over a country to see the number of online article views and PDF downloads from Cureus only.
Note: PMC does not share location data and not all Cureus reads are included below as location data is not available for all IP addresses.


Rank Country Views Percentage

Article Reads by U.S. States

Hover your cursor over a state to see the number of online article views and PDF downloads from Cureus only.
Note: PMC does not share location data and not all Cureus reads are included below as location data is not available for all IP addresses.


Rank State Views Percentage

Citations

Citation index reporting varies. Crossref citations are listed below and Google Scholar citations can be seen by clicking the corresponding button.

Google Scholar  
Crossref Citations (126)
  1. Xiang, P., Xu, X., Lu, X., Gao, L., Wang, H., Li, Z., … Liu, J. (2021). Case Report: Identification of SARS-CoV-2 in Cerebrospinal Fluid by Ultrahigh-Depth Sequencing in a Patient With Coronavirus Disease 2019 and Neurological Dysfunction. Frontiers in Medicine, 8. doi:10.3389/fmed.2021.629828.
  2. Toljan, K. (2020). Letter to the Editor Regarding the Viewpoint “Evidence of the COVID-19 Virus Targeting the CNS: Tissue Distribution, Host–Virus Interaction, and Proposed Neurotropic Mechanism.” ACS Chemical Neuroscience, 11(8), 1192–1194. doi:10.1021/acschemneuro.0c00174.
  3. ŞİMŞEKOĞLU, R., & TOMBUL, T. (2020). Covid-19 Pandemic and Neurological Manifestations. Anadolu Kliniği Tıp Bilimleri Dergisi. doi:10.21673/anadoluklin.738020.
  4. Mirza, J., Ganguly, A., Ostrovskaya, A., Tusher, A., & Viswanathan, R. (2020). Command Suicidal Hallucination as Initial Presentation of Coronavirus Disease 2019 (COVID-19): A Case Report. Psychosomatics. doi:10.1016/j.psym.2020.05.022.
  5. Franceschi, A. M., Ahmed, O., Giliberto, L., & Castillo, M. (2020). Hemorrhagic Posterior Reversible Encephalopathy Syndrome as a Manifestation of COVID-19 Infection. American Journal of Neuroradiology. doi:10.3174/ajnr.A6595.
  6. Pérez Álvarez, Á. I., Suárez Cuervo, C., & Fernández Menéndez, S. (2020). Infección por SARS-CoV-2 asociada a diplopía y anticuerpos antirreceptor de acetilcolina. Neurología, 35(4), 264–265. doi:10.1016/j.nrl.2020.04.003.
  7. Pryce-Roberts, A., Talaei, M., & Robertson, N. P. (2020). Neurological complications of COVID-19: a preliminary review. Journal of Neurology, 267(6), 1870–1873. doi:10.1007/s00415-020-09941-x.
  8. Baj, J., Karakuła-Juchnowicz, H., Teresiński, G., Buszewicz, G., Ciesielka, M., Sitarz, E., … Maciejewski, R. (2020). COVID-19: Specific and Non-Specific Clinical Manifestations and Symptoms: The Current State of Knowledge. Journal of Clinical Medicine, 9(6), 1753. doi:10.3390/jcm9061753.
  9. Resource not found. doi:10.3174/ajnr.A6651.
  10. Zhou, Z., Kang, H., Li, S., & Zhao, X. (2020). Understanding the neurotropic characteristics of SARS-CoV-2: from neurological manifestations of COVID-19 to potential neurotropic mechanisms. Journal of Neurology. doi:10.1007/s00415-020-09929-7.
  11. Pastor, J., Vega-Zelaya, L., & Martín Abad, E. (2020). Specific EEG Encephalopathy Pattern in SARS-CoV-2 Patients. Journal of Clinical Medicine, 9(5), 1545. doi:10.3390/jcm9051545.
  12. Leonardi, M., Padovani, A., & McArthur, J. C. (2020). Neurological manifestations associated with COVID-19: a review and a call for action. Journal of Neurology, 267(6), 1573–1576. doi:10.1007/s00415-020-09896-z.
  13. Lantos, J. E., Strauss, S. B., & Lin, E. (2020). COVID-19–Associated Miller Fisher Syndrome: MRI Findings. American Journal of Neuroradiology. doi:10.3174/ajnr.A6609.
  14. Gómez-Iglesias, P., Porta-Etessam, J., Montalvo, T., Valls-Carbó, A., Gajate, V., Matías-Guiu, J. A., … Matías-Guiu, J. (2020). An Online Observational Study of Patients With Olfactory and Gustory Alterations Secondary to SARS-CoV-2 Infection. Frontiers in Public Health, 8. doi:10.3389/fpubh.2020.00243.
  15. Gklinos, P. (2020). Neurological manifestations of COVID-19: a review of what we know so far. Journal of Neurology. doi:10.1007/s00415-020-09939-5.
  16. Niazkar, H. R., Zibaee, B., Nasimi, A., & Bahri, N. (2020). The neurological manifestations of COVID-19: a review article. Neurological Sciences. doi:10.1007/s10072-020-04486-3.
  17. Berger, J. R. (2020). COVID-19 and the nervous system. Journal of NeuroVirology, 26(2), 143–148. doi:10.1007/s13365-020-00840-5.
  18. Franceschi, A. M., Arora, R., Wilson, R., Giliberto, L., Libman, R. B., & Castillo, M. (2020). Neurovascular Complications in COVID-19 Infection: Case Series. American Journal of Neuroradiology. doi:10.3174/ajnr.A6655.
  19. Pérez Álvarez, Á. I., Suárez Cuervo, C., & Fernández Menéndez, S. (2020). SARS-CoV-2 infection associated with diplopia and anti-acetylcholine receptor antibodies. Neurología (English Edition), 35(4), 264–265. doi:10.1016/j.nrleng.2020.04.003.
  20. Padda, I., Khehra, N., Jaferi, U., & Parmar, M. S. (2020). The Neurological Complexities and Prognosis of COVID-19. SN Comprehensive Clinical Medicine. doi:10.1007/s42399-020-00527-2.
  21. Chotani, R. A., Ashraf, S. S., Aziz, F., Thakurdas, S. M., Chotani, A., Ashraf, A., … Cheema, F. H. (2020). Case Report: Longitudinal assessment of a COVID-19 patient in the midst of a pandemic. F1000Research, 9, 972. doi:10.12688/f1000research.24911.1.
  22. Barrantes, F. J. (2020). Central Nervous System Targets and Routes for SARS-CoV-2: Current Views and New Hypotheses. ACS Chemical Neuroscience, 11(18), 2793–2803. doi:10.1021/acschemneuro.0c00434.
  23. Pennisi, M., Lanza, G., Falzone, L., Fisicaro, F., Ferri, R., & Bella, R. (2020). SARS-CoV-2 and the Nervous System: From Clinical Features to Molecular Mechanisms. International Journal of Molecular Sciences, 21(15), 5475. doi:10.3390/ijms21155475.
  24. Resource not found. doi:10.1038/s41398-020-00949-5.
  25. Al Mazrouei, S. S., Saeed, G. A., Al Helali, A. A., & Ahmed, M. (2020). COVID-19-associated encephalopathy: Neurological manifestation of COVID-19. Radiology Case Reports, 15(9), 1646–1649. doi:10.1016/j.radcr.2020.07.009.
  26. Roy, D., Hollingworth, M., & Kumaria, A. (2020). A case of malignant cerebral infarction associated with COVID-19 infection. British Journal of Neurosurgery, 1–4. doi:10.1080/02688697.2020.1779180.
  27. The Brain Damage of COVID-19. (2020). Medical & Clinical Research, 5(Special). doi:10.33140/MCR.05.008.
  28. Barranco, M. R., García, L. R., Quiles, J. L., Sánchez, D. R., Ramírez, P. A., González, J. L., … González, C. S. (2020). The spread of SARS-CoV-2 in Spain: hygiene habits, sociodemographic profile, mobility patterns and comorbidities. Environmental Research, 110223. doi:10.1016/j.envres.2020.110223.
  29. Bodro, M., Compta, Y., Llansó, L., Esteller, D., Doncel-Moriano, A., Mesa, A., … García, F. (2020). Increased CSF levels of IL-1β, IL-6, and ACE in SARS-CoV-2–associated encephalitis. Neurology - Neuroimmunology Neuroinflammation, 7(5), e821. doi:10.1212/NXI.0000000000000821.
  30. Chowdhury, M. E. H., Rahman, T., Khandakar, A., Mazhar, R., Kadir, M. A., Mahbub, Z. B., … Islam, M. T. (2020). Can AI Help in Screening Viral and COVID-19 Pneumonia? IEEE Access, 8, 132665–132676. doi:10.1109/ACCESS.2020.3010287.
  31. Azim, D., Nasim, S., Kumar, S., Hussain, A., & Patel, S. (2020). Neurological Consequences of 2019-nCoV Infection: A Comprehensive Literature Review. Cureus. doi:10.7759/cureus.8790.
  32. Kirksey, M. A., Yang, E. I., Kuvadia, M., & Miller, A. O. (2020). Management Considerations for the COVID-19 Patient with Severe Disease: a Case Scenario and Literature Review. HSS Journal ®. doi:10.1007/s11420-020-09789-x.
  33. Gavriilaki, E., Anyfanti, P., Gavriilaki, M., Lazaridis, A., Douma, S., & Gkaliagkousi, E. (2020). Endothelial Dysfunction in COVID-19: Lessons Learned from Coronaviruses. Current Hypertension Reports, 22(9). doi:10.1007/s11906-020-01078-6.
  34. Soltani Zangbar, H., Gorji, A., & Ghadiri, T. (2020). A Review on the Neurological Manifestations of COVID-19 Infection: a Mechanistic View. Molecular Neurobiology. doi:10.1007/s12035-020-02149-0.
  35. Orrù, G., Conversano, C., Malloggi, E., Francesconi, F., Ciacchini, R., & Gemignani, A. (2020). Neurological Complications of COVID-19 and Possible Neuroinvasion Pathways: A Systematic Review. International Journal of Environmental Research and Public Health, 17(18), 6688. doi:10.3390/ijerph17186688.
  36. Rahman, A., Niloofa, R., De Zoysa, I. M., Cooray, A. D., Kariyawasam, J., & Seneviratne, S. L. (2020). Neurological manifestations in COVID-19: A narrative review. SAGE Open Medicine, 8, 205031212095792. doi:10.1177/2050312120957925.
  37. Alexeeva, N. T., Sokolov, D. A., Nikityuk, D. B., Klochkova, S. V., & Kvaratskheliya, A. G. (2020). Molecular and cellular mechanisms of central nervous system alteration in COVID-19. Journal of Anatomy and Histopathology, 9(3), 72–85. doi:10.18499/2225-7357-2020-9-3-72-85.
  38. Romero, A., Ramos, E., López-Muñoz, F., Gil-Martín, E., Escames, G., & Reiter, R. J. (2020). Coronavirus Disease 2019 (COVID-19) and Its Neuroinvasive Capacity: Is It Time for Melatonin? Cellular and Molecular Neurobiology. doi:10.1007/s10571-020-00938-8.
  39. Keng, A., Brown, E. E., Rostas, A., Rajji, T. K., Pollock, B. G., Mulsant, B. H., & Kumar, S. (2020). Effectively Caring for Individuals With Behavioral and Psychological Symptoms of Dementia During the COVID-19 Pandemic. Frontiers in Psychiatry, 11. doi:10.3389/fpsyt.2020.573367.
  40. Novikova, L. B., Akopian, A. P., Sharapova, K. M., & Latypova, R. F. (2020). Neurological and mental disorders associated with COVID-19. “Arterial’naya Gipertenziya” (“Arterial Hypertension”), 26(3), 317–326. doi:10.18705/1607-419X-2020-26-3-317-326.
  41. Herman, C., Mayer, K., & Sarwal, A. (2020). Scoping review of prevalence of neurologic comorbidities in patients hospitalized for COVID-19. Neurology, 95(2), 77–84. doi:10.1212/WNL.0000000000009673.
  42. Khan, S., & Gomes, J. (2020). Neuropathogenesis of SARS-CoV-2 infection. eLife, 9. doi:10.7554/eLife.59136.
  43. Wong, A., Roppolo, L., Chang, B., Yonkers, K., Wilson, M., Powsner, S., & Rozel, J. (2020). Management of Agitation During the COVID-19 Pandemic. Western Journal of Emergency Medicine, 21(4). doi:10.5811/westjem.2020.5.47789.
  44. Bhuiyan, M. N., Ganesh, R., & Ghosh, A. K. (2020). COVID-19: A 2020 update. Indian Journal of Medical Sciences, 72, 88–94. doi:10.25259/IJMS_123_2020.
  45. Pincherle, A., Jöhr, J., Pancini, L., Leocani, L., Dalla Vecchia, L., Ryvlin, P., … Diserens, K. (2020). Intensive Care Admission and Early Neuro-Rehabilitation. Lessons for COVID-19? Frontiers in Neurology, 11. doi:10.3389/fneur.2020.00880.
  46. Pirau, L., Ottenhoff, L., Williamson, C. A., Ahmad, S. N., Wabl, R., Nguyen, A., … Rajajee, V. (2020). Case Series: Evidence of Borderzone Ischemia in Critically-Ill COVID-19 Patients Who “Do Not Wake Up.” Frontiers in Neurology, 11. doi:10.3389/fneur.2020.00964.
  47. Mosolov, S. N. (2020). Problems of mental health in the situation of COVID-19 pandemic. Zhurnal Nevrologii i Psikhiatrii Im. S.S. Korsakova, 120(5), 7. doi:10.17116/jnevro20201200517.
  48. Putilina, M. V., & Grishin, D. V. (2020). SARS-CoV-2 (COVID-19) as a predictor of neuroinflammation and neurodegeneration: potential therapy strategies. Zhurnal Nevrologii i Psikhiatrii Im. S.S. Korsakova, 120(8), 58. doi:10.17116/jnevro202012008258.
  49. Goldberg, M. F., & Goldberg, M. F. (2020). Neuroradiologic manifestations of COVID-19: what the emergency radiologist needs to know. Emergency Radiology. doi:10.1007/s10140-020-01840-y.
  50. Abobaker, A., Raba, A. A., & Alzwi, A. (2020). Extrapulmonary and atypical clinical presentations of COVID‐19. Journal of Medical Virology, 92(11), 2458–2464. doi:10.1002/jmv.26157.
  51. Ashraf, M., & Sajed, S. (2020). Seizures Related to Coronavirus Disease (COVID-19): Case Series and Literature Review. Cureus. doi:10.7759/cureus.9378.
  52. Fucini, J., & Jean-Pierre, T. (2020). A-7 nAchR Macrophages and Nicotine Approach in Neuroprotection to COVID-19 4 Variables Equation? SSRN Electronic Journal. doi:10.2139/ssrn.3674367.
  53. Nepal, G., Rehrig, J. H., Shrestha, G. S., Shing, Y. K., Yadav, J. K., Ojha, R., … Huang, D. Y. (2020). Neurological manifestations of COVID-19: a systematic review. Critical Care, 24(1). doi:10.1186/s13054-020-03121-z.
  54. Guadarrama-Ortiz, P., Choreño-Parra, J. A., Sánchez-Martínez, C. M., Pacheco-Sánchez, F. J., Rodríguez-Nava, A. I., & García-Quintero, G. (2020). Neurological Aspects of SARS-CoV-2 Infection: Mechanisms and Manifestations. Frontiers in Neurology, 11. doi:10.3389/fneur.2020.01039.
  55. Khatoon, F., Prasad, K., & Kumar, V. (2020). Neurological manifestations of COVID-19: available evidences and a new paradigm. Journal of NeuroVirology, 26(5), 619–630. doi:10.1007/s13365-020-00895-4.
  56. Neurological Complications of COVID 19. (2020). Medical & Clinical Research, 5(Special). doi:10.33140/MCR.05.004.
  57. Shkurovich-Bialik, P.,  Evangelio-Miranda, J. D., & Maldonado-Torres, G. Á. (2020). Hallazgos electroencefalográficos en pacientes con diagnóstico confirmado de SARS-CoV-2/COVID-19. Anales Médicos de La Asociación Médica Del Centro Médico ABC, 65(3), 194–200. doi:10.35366/95676.
  58. Sozzi, M., Algeri, L., Corsano, M., Crivelli, D., Daga, M. A., Fumagalli, F., … Balconi, M. (2020). Neuropsychology in the Times of COVID-19. The Role of the Psychologist in Taking Charge of Patients With Alterations of Cognitive Functions. Frontiers in Neurology, 11. doi:10.3389/fneur.2020.573207.
  59. Gasmi, A., Tippairote, T., Mujawdiya, P. K., Gasmi Benahmed, A., Menzel, A., Dadar, M., & Bjørklund, G. (2020). Neurological Involvements of SARS-CoV2 Infection. Molecular Neurobiology. doi:10.1007/s12035-020-02070-6.
  60. Alshebri, M. S., Alshouimi, R. A., Alhumidi, H. A., & Alshaya, A. I. (2020). Neurological Complications of SARS-CoV, MERS-CoV, and COVID-19. SN Comprehensive Clinical Medicine. doi:10.1007/s42399-020-00589-2.
  61. Favas, T. T., Dev, P., Chaurasia, R. N., Chakravarty, K., Mishra, R., Joshi, D., … Pathak, A. (2020). Neurological manifestations of COVID-19: a systematic review and meta-analysis of proportions. Neurological Sciences. doi:10.1007/s10072-020-04801-y.
  62. Augustine, R., Das, S., Hasan, A., S, A., Abdul Salam, S., Augustine, P., … Kevadiya, B. D. (2020). Rapid Antibody-Based COVID-19 Mass Surveillance: Relevance, Challenges, and Prospects in a Pandemic and Post-Pandemic World. Journal of Clinical Medicine, 9(10), 3372. doi:10.3390/jcm9103372.
  63. Pergolizzi, J. V., Raffa, R. B., Varrassi, G., Magnusson, P., LeQuang, J. A., Paladini, A., … Christo, P. J. (2020). Potential Neurological Manifestations of COVID-19: A Narrative Review. Postgraduate Medicine. doi:10.1080/00325481.2020.1837503.
  64. Rito, T., Richards, M. B., Pala, M., Correia-Neves, M., & Soares, P. A. (2020). Phylogeography of 27,000 SARS-CoV-2 Genomes: Europe as the Major Source of the COVID-19 Pandemic. Microorganisms, 8(11), 1678. doi:10.3390/microorganisms8111678.
  65. Somer, E., Abu-Rayya, H. M., Schimmenti, A., Metin, B., Brenner, R., Ferrante, E., … Marino, A. (2020). Heightened Levels of Maladaptive Daydreaming Are Associated With COVID-19 Lockdown, Pre-existing Psychiatric Diagnoses, and Intensified Psychological Dysfunctions: A Multi-country Study. Frontiers in Psychiatry, 11. doi:10.3389/fpsyt.2020.587455.
  66. SAHİN, A., GÜLTEKİN, A., GÜCER ŞAHİN, G., YILDIRIM, İ., MORDENİZ, C., & ARAR, C. (2020). COVID-19 Pandemi Sırasındaki Acil Cerrahi Bakım ve Ameliyathane Uygulamalarında Perioperatif Uygulama ve Rehberlik; Deneyimlerimiz. Namık Kemal Tıp Dergisi. doi:10.37696/nkmj.771489.
  67. Rodriguez, M., Soler, Y., Perry, M., Reynolds, J. L., & El-Hage, N. (2020). Impact of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in the Nervous System: Implications of COVID-19 in Neurodegeneration. Frontiers in Neurology, 11. doi:10.3389/fneur.2020.583459.
  68. BİLGE, N., KESMEZ CAN, F., & ALAY, H. (2020). The Relationship of Headache with Inflammatory Serum Parameters and Disease Severity in COVID-19 Patients. Düzce Tıp Fakültesi Dergisi. doi:10.18678/dtfd.776731.
  69. Zareef, R. O., Younis, N. K., Bitar, F., Eid, A. H., & Arabi, M. (2020). COVID-19 in Pediatric Patients: A Focus on CHD Patients. Frontiers in Cardiovascular Medicine, 7. doi:10.3389/fcvm.2020.612460.
  70. Besnard, S., Nardin, C., Lyon, E., Debroucker, T., Arjmand, R., Moretti, R., & Pochat, H. (2020). Electroencephalographic Abnormalites in SARS-CoV-2 Patients. Frontiers in Neurology, 11. doi:10.3389/fneur.2020.582794.
  71. Pastor, J., Vega-Zelaya, L., & Martín Abad, E. (2020). Necessity of Quantitative EEG for Daily Clinical Practice. Electroencephalography [Working Title]. doi:10.5772/intechopen.94549.
  72. Yu, H., Sun, T., & Feng, J. (2020). Complications and Pathophysiology of COVID-19 in the Nervous System. Frontiers in Neurology, 11. doi:10.3389/fneur.2020.573421.
  73. Mekonnen, H. S., Azagew, A. W., Wubneh, C. A., Belay, G. M., Assimamaw, N. T., Agegnehu, C. D., … Alemayehu, M. (2020). Community’s misconception about COVID-19 and its associated factors among Gondar town residents, Northwest Ethiopia. Tropical Medicine and Health, 48(1). doi:10.1186/s41182-020-00279-8.
  74. Seyed Ahadi, M., Rezaeimanesh, N., & Naser Moghadasi, A. (2020). Neuropsychiatric Complications of COVID-19: What is to be Expected. Archives of Neuroscience, 8(1). doi:10.5812/ans.107111.
  75. Yu, S., & Yu, M. (2020). Severe Acute Respiratory Syndrome Coronavirus 2-Induced Neurological Complications. Frontiers in Cell and Developmental Biology, 8. doi:10.3389/fcell.2020.605972.
  76. Orrù, G., Bertelloni, D., Diolaiuti, F., Mucci, F., Di Giuseppe, M., Biella, M., … Conversano, C. (2021). Long-COVID Syndrome? A Study on the Persistence of Neurological, Psychological and Physiological Symptoms. Healthcare, 9(5), 575. doi:10.3390/healthcare9050575.
  77. Thangaraj, M., Lakshmi, R. A., & Shankar, P. L. (2021). NEUROLOGICAL MANIFESTATIONS OF COVID IN A TERTIARY CARE CENTER IN TAMILNADU. INDIAN JOURNAL OF APPLIED RESEARCH, 1–3. doi:10.36106/ijar/5300167.
  78. Karimi, L., Sales, C., Crewther, S. G., & Wijeratne, T. (2020). Acute Ischemic Stroke in SARS-CoV, MERS-CoV, SARS-CoV-2: Neurorehabilitation Implications of Inflammation Induced Immunological Responses Affecting Vascular Systems. Frontiers in Neurology, 11. doi:10.3389/fneur.2020.565665.
  79. Odriozola, A., Ortega, L., Martinez, L., Odriozola, S., Torrens, A., Corroleu, D., … Malik, R. A. (2021). Widespread sensory neuropathy in diabetic patients hospitalized with severe COVID-19 infection. Diabetes Research and Clinical Practice, 172, 108631. doi:10.1016/j.diabres.2020.108631.
  80. Taher, T., Sheikh, A. B., Anwar, F., & Khosa, F. (2021). SARS-CoV-2: its potential neurological manifestations and plausible mechanism: a review article. Acta Neurologica Belgica. doi:10.1007/s13760-020-01577-y.
  81. Fakhri, S., Piri, S., Majnooni, M. B., Farzaei, M. H., & Echeverría, J. (2021). Targeting Neurological Manifestations of Coronaviruses by Candidate Phytochemicals: A Mechanistic Approach. Frontiers in Pharmacology, 11. doi:10.3389/fphar.2020.621099.
  82. Kumari, P., Rothan, H. A., Natekar, J. P., Stone, S., Pathak, H., Strate, P. G., … Kumar, M. (2021). Neuroinvasion and Encephalitis Following Intranasal Inoculation of SARS-CoV-2 in K18-hACE2 Mice. Viruses, 13(1), 132. doi:10.3390/v13010132.
  83. Harapan, B. N., & Yoo, H. J. (2021). Neurological symptoms, manifestations, and complications associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease 19 (COVID-19). Journal of Neurology. doi:10.1007/s00415-021-10406-y.
  84. Ermilov, V. V., Barkanov, V. B., Barkanova, O. N., Dorofeev, N. A., & Filatov, V. E. (2021). Clinical and anatomical features of SARS-COV-2 with acute hemorrhagic necrotizing encephalopathy. Arkhiv Patologii, 83(1), 35. doi:10.17116/patol20218301135.
  85. Fisicaro, F., Di Napoli, M., Liberto, A., Fanella, M., Di Stasio, F., Pennisi, M., … Mansueto, G. (2021). Neurological Sequelae in Patients with COVID-19: A Histopathological Perspective. International Journal of Environmental Research and Public Health, 18(4), 1415. doi:10.3390/ijerph18041415.
  86. Veronese, S., & Sbarbati, A. (2021). Chemosensory Systems in COVID-19: Evolution of Scientific Research. ACS Chemical Neuroscience. doi:10.1021/acschemneuro.0c00788.
  87. Kurushina, O. V., & Barulin, A. E. (2021). Effects of COVID-19 on the central nervous system. Zhurnal Nevrologii i Psikhiatrii Im. S.S. Korsakova, 121(1), 92. doi:10.17116/jnevro202112101192.
  88. Yazdanpanah, N., Saghazadeh, A., & Rezaei, N. (2020). Anosmia: a missing link in the neuroimmunology of coronavirus disease 2019 (COVID-19). Reviews in the Neurosciences, 31(7), 691–701. doi:10.1515/revneuro-2020-0039.
  89. Williams-Medina, A., Deblock, M., & Janigro, D. (2021). In vitro Models of the Blood–Brain Barrier: Tools in Translational Medicine. Frontiers in Medical Technology, 2. doi:10.3389/fmedt.2020.623950.
  90. Waheed, S., Bayas, A., Hindi, F., Rizvi, Z., & Espinosa, P. S. (2021). Neurological Complications of COVID-19: Guillain-Barre Syndrome Following Pfizer COVID-19 Vaccine. Cureus. doi:10.7759/cureus.13426.
  91. Campagnano, S., Angelini, F., Fonsi, G. B., Novelli, S., & Drudi, F. M. (2021). Diagnostic imaging in COVID-19 pneumonia: a literature review. Journal of Ultrasound. doi:10.1007/s40477-021-00559-x.
  92. Vellieux, G., Sonneville, R., Vledouts, S., Jaquet, P., Rouvel-Tallec, A., & d’ Ortho, M.-P. (2021). COVID-19-Associated Neurological Manifestations: An Emerging Electroencephalographic Literature. Frontiers in Physiology, 11. doi:10.3389/fphys.2020.622466.
  93. Gonçalves de Andrade, E., Šimončičová, E., Carrier, M., Vecchiarelli, H. A., Robert, M.-È., & Tremblay, M.-È. (2021). Microglia Fighting for Neurological and Mental Health: On the Central Nervous System Frontline of COVID-19 Pandemic. Frontiers in Cellular Neuroscience, 15. doi:10.3389/fncel.2021.647378.
  94. Talluri, K., Lall, N., Moreno, M. A., Nichols, L., & Bande, D. (2021). Posterior Reversible Encephalopathy Syndrome in a Patient With SARS-CoV-2 Infection Treated With Tocilizumab. Cureus. doi:10.7759/cureus.13475.
  95. Singh, S., Ahirwar, A. K., Asia, P., Gopal, N., Kaim, K., & Ahirwar, P. (2021). COVID-19 and neurology perspective. Hormone Molecular Biology and Clinical Investigation, 0(0). doi:10.1515/hmbci-2020-0069.
  96. Ng, S. L., Ong, Y. S., Khaw, K. Y., Teh, S. P., Tan, C. S., Ming, L. C., … Goh, B.-H. (2021). Focused Review: Potential Rare and Atypical Symptoms as Indicator for Targeted COVID-19 Screening. Medicina, 57(2), 189. doi:10.3390/medicina57020189.
  97. Teodorescu, M. (2021). An Overview of a Year with COVID-19: What We Know? Electronic Journal of General Medicine, 18(3), em286. doi:10.29333/ejgm/9765.
  98. Daneshfar, Z., Jahanian Sadatmahalleh, S., Youseflu, S., Bahri Khomami, M., & Kazemnejad, A. (2021). Influential factors on quality of life in married Iranian women during the COVID-19 pandemic in 2020: a path analysis. BMC Women’s Health, 21(1). doi:10.1186/s12905-020-01114-2.
  99. Al-Ramadan, A., Rabab’h, O., Shah, J., & Gharaibeh, A. (2021). Acute and Post-Acute Neurological Complications of COVID-19. Neurology International, 13(1), 102–119. doi:10.3390/neurolint13010010.
  100. Bhadoria, P., & Rathore, H. (2021). Multi-Organ System Dysfunction in Covid-19 – A Review. Journal of Evolution of Medical and Dental Sciences, 10(9), 632–637. doi:10.14260/jemds/2021/135.
  101. Manara, O., Pezzetti, G., & Gerevini, S. (2021). Posterior Reversible Encephalopathy Syndrome (PRES) and Meningo-Encephalitis in COVID. Neuroimaging of Covid-19. First Insights Based on Clinical Cases, 39–67. doi:10.1007/978-3-030-67521-9_4.
  102. Malone, R. W., Tisdall, P., Fremont-Smith, P., Liu, Y., Huang, X.-P., White, K. M., … Ricke, D. O. (2021). COVID-19: Famotidine, Histamine, Mast Cells, and Mechanisms. Frontiers in Pharmacology, 12. doi:10.3389/fphar.2021.633680.
  103. Hartog, N., Faber, W., Frisch, A., Bauss, J., Bupp, C. P., Rajasekaran, S., & Prokop, J. W. (2021). SARS-CoV-2 infection: molecular mechanisms of severe outcomes to suggest therapeutics. Expert Review of Proteomics. doi:10.1080/14789450.2021.1908894.
  104. Yassin, A., Nawaiseh, M., Shaban, A., Alsherbini, K., El-Salem, K., Soudah, O., & Abu-Rub, M. (2021). Neurological manifestations and complications of coronavirus disease 2019 (COVID-19): a systematic review and meta-analysis. BMC Neurology, 21(1). doi:10.1186/s12883-021-02161-4.
  105. Mokhtari, A. K., Maurer, L. R., Christensen, M. A., Moheb, M. E., Naar, L., Alser, O., … Kaafarani, H. M. A. (2021). Rhabdomyolysis in Severe COVID-19: male sex, high BMI, and prone positioning confer high risk. Journal of Surgical Research. doi:10.1016/j.jss.2021.03.049.
  106. Ramakrishna, J. M., Libertin, C. R., Siegel, J., Binnicker, M. J., Harris, D., Matcha, G. V., … Freeman, W. D. (2020). Three-tier stratification for CNS COVID-19 to help decide which patients should undergo lumbar puncture with CSF analysis: A case report and literature review. Romanian Journal of Internal Medicine, 0(0). doi:10.2478/rjim-2020-0031.
  107. Stracciari, A., Bottini, G., Guarino, M., Magni, E., & Pantoni, L. (2021). Cognitive and behavioral manifestations in SARS-CoV-2 infection: not specific or distinctive features? Neurological Sciences. doi:10.1007/s10072-021-05231-0.
  108. Noce, A., Albanese, M., Marrone, G., Di Lauro, M., Pietroboni Zaitseva, A., Palazzetti, D., … Di Daniele, N. (2021). Ultramicronized Palmitoylethanolamide (um-PEA): A New Possible Adjuvant Treatment in COVID-19 patients. Pharmaceuticals, 14(4), 336. doi:10.3390/ph14040336.
  109. Shehata, G. A., Lord, K. C., Grudzinski, M. C., Elsayed, M., Abdelnaby, R., & Elshabrawy, H. A. (2021). Neurological Complications of COVID-19: Underlying Mechanisms and Management. International Journal of Molecular Sciences, 22(8), 4081. doi:10.3390/ijms22084081.
  110. ARSLAN, M. (2021). COVID-19 and the Nervous System. SDÜ Tıp Fakültesi Dergisi. doi:10.17343/sdutfd.908277.
  111. AYDEMİR, D., TÜRK, Ö., CEYLAN, B., YILDIRIM, N., BAYLAM, E., KOÇKAR, İ. N., … ŞENGEZE, N. (2021). COVID-19 ve NÖROLOJİK HASTALIKLAR. SDÜ Tıp Fakültesi Dergisi. doi:10.17343/sdutfd.920618.
  112. Teimouri-Jervekani, Z., & Salmasi, M. (2021). Presentation of COVID-19 infection with bizarre behavior and encephalopathy: a case report. Journal of Medical Case Reports, 15(1). doi:10.1186/s13256-021-02851-0.
  113. Mawhinney, J. A., Wilcock, C., Haboubi, H., & Roshanzamir, S. (2020). Neurotropism of SARS-CoV-2: COVID-19 presenting with an acute manic episode. BMJ Case Reports, 13(6), e236123. doi:10.1136/bcr-2020-236123.
  114. Pinzon, R. T., Wijaya, V. O., Buana, R. B., Al Jody, A., & Nunsio, P. N. (2020). Neurologic Characteristics in Coronavirus Disease 2019 (COVID-19): A Systematic Review and Meta-Analysis. Frontiers in Neurology, 11. doi:10.3389/fneur.2020.00565.
  115. Carda, S., Invernizzi, M., Bavikatte, G., Bensmaïl, D., Bianchi, F., Deltombe, T., … Molteni, F. (2020). The role of physical and rehabilitation medicine in the COVID-19 pandemic: The clinician’s view. Annals of Physical and Rehabilitation Medicine. doi:10.1016/j.rehab.2020.04.001.
  116. Tsai, S.-T., Lu, M.-K., San, S., & Tsai, C.-H. (2020). The Neurologic Manifestations of Coronavirus Disease 2019 Pandemic: A Systemic Review. Frontiers in Neurology, 11. doi:10.3389/fneur.2020.00498.
  117. Barker-Davies, R. M., O’Sullivan, O., Senaratne, K. P. P., Baker, P., Cranley, M., Dharm-Datta, S., … Bahadur, S. (2020). The Stanford Hall consensus statement for post-COVID-19 rehabilitation. British Journal of Sports Medicine, bjsports–2020–102596. doi:10.1136/bjsports-2020-102596.
  118. Al Kasab, S., Almallouhi, E., Alawieh, A., Levitt, M. R., Jabbour, P., Sweid, A., … Spiotta, A. M. (2020). International experience of mechanical thrombectomy during the COVID-19 pandemic: insights from STAR and ENRG. Journal of NeuroInterventional Surgery, neurintsurg–2020–016671. doi:10.1136/neurintsurg-2020-016671.
  119. (2020). Guía COVID-19 para la atención del paciente crítico con infección por SARS-coV-2 Colegio Mexicano de Medicina Crítica, (segunda parte). Medicina Crítica, 34(2), 99–124. doi:10.35366/93964.
  120. Verma, K., Amitabh, Prasad, D. N., Kumar, B., & Kohli, E. (2020). Brain and COVID-19 Crosstalk: Pathophysiological and Psychological Manifestations. ACS Chemical Neuroscience. doi:10.1021/acschemneuro.0c00446.
  121. Romero-Sánchez, C. M., Díaz-Maroto, I., Fernández-Díaz, E., Sánchez-Larsen, Á., Layos-Romero, A., García-García, J., … Segura, T. (2020). Neurologic manifestations in hospitalized patients with COVID-19. Neurology, 95(8), e1060–e1070. doi:10.1212/WNL.0000000000009937.
  122. Macera, M., De Angelis, G., Sagnelli, C., & Coppola, N. (2020). Clinical Presentation of COVID-19: Case Series and Review of the Literature. International Journal of Environmental Research and Public Health, 17(14), 5062. doi:10.3390/ijerph17145062.
  123. Hassanzadeh, K., Perez Pena, H., Dragotto, J., Buccarello, L., Iorio, F., Pieraccini, S., … Feligioni, M. (2020). Considerations around the SARS-CoV-2 Spike Protein with Particular Attention to COVID-19 Brain Infection and Neurological Symptoms. ACS Chemical Neuroscience, 11(15), 2361–2369. doi:10.1021/acschemneuro.0c00373.
  124. Ternovyh, I. K., Topuzova, M. P., Chaykovskaya, A. D., Isabekova, P. S., & Alekseeva, T. M. (2020). Neurological manifestations and complications in patients with covid-19. Translational Medicine, 7(3), 21–29. doi:10.18705/2311-4495-2020-7-3-21-29.
  125. Bellocchio, L., Bordea, I. R., Ballini, A., Lorusso, F., Hazballa, D., Isacco, C. G., … Miani, A. (2020). Environmental Issues and Neurological Manifestations Associated with COVID-19 Pandemic: New Aspects of the Disease? International Journal of Environmental Research and Public Health, 17(21), 8049. doi:10.3390/ijerph17218049.
  126. Sangare, A., Dong, A., Valente, M., Pyatigorskaya, N., Cao, A., Altmayer, V., … Naccache, L. (2020). Neuroprognostication of Consciousness Recovery in a Patient with COVID-19 Related Encephalitis: Preliminary Findings from a Multimodal Approach. Brain Sciences, 10(11), 845. doi:10.3390/brainsci10110845.

Article Research Metrics

We’ve partnered with Plum Analytics to track and display research metrics for each article. (All data provided by PlumX Metrics.) Click here to learn more about Plum Analytics.